306 research outputs found

    State of the Art and New Trends from the 2022 Gism Annual Meeting

    Get PDF
    The 2022 Italian Mesenchymal Stem Cell Group (Gruppo Italiano Staminali Mesenchimali, GISM) Annual Meeting took place on 20–21 October 2022 in Turin (Italy), with the support of the University of Turin and the City of Health and Science of Turin. The novelty of this year’s meeting was its articulation, reflecting the new structure of GISM based on six sections: (1) Bringing advanced therapies to the clinic: trends and strategies, (2) GISM Next Generation, (3) New technologies for 3D culture systems, (4) Therapeutic applications of MSC-EVs in veterinary and human medicine, (5) Advancing MSC therapies in veterinary medicine: present challenges and future perspectives, (6) MSCs: a double-edged sword: friend or foe in oncology. National and international speakers presented their scientific works with the aim of promoting an interactive discussion and training for all attendees. The atmosphere was interactive, where ideas and questions between younger researchers and senior mentors were shared in all moments of the congress

    3D Bioprinted Engineered Living Materials for Continuous Organophosphorus Compound Detoxification

    Get PDF
    Engineered living materials (ELMs) are a rapidly emerging class of materials, demonstrating a wide range of functionalities, including responsive morphing, self-healing, and bio-catalysis. 3D bioprinted hydrogels have been used for the fabrication of high resolution, compartmentalised, and load-bearing structures suitable for hosting microbial metabolism, and accordingly represent an ideal environment for ELMs. The interactions between material frameworks, such as hydrogels, and encapsulated life are now beginning to be investigated.Herein, by 3D printing a hydrogel-encapsulated population of Escherichia coli, a chemically inducible, metabolically active, microbial ELM was fabricated. The material was characterised using a wide range of techniques, including fluorescence microscopy and cryogenic electron microscopy. Toxic organophosphorus compound (OPC) detoxifying capabilities were conveyed to the material through inducible expression of Agrobacterium radiobacter phosphotriesterase (arPTE). The reaction diffusion process occurring at the interface of the OPC detoxifying ELM was investigated using continuous fluorescence imaging of Coumaphos hydrolysis.. Principal component analysis was then used to uncover spatial and temporal features within this data, with relevance for future optimisation of catalytic microbial ELMstructures. To further demonstrate the applicability of this 3D printable microbial ELM, the material was incorporated into an entirely 3D printed flow reactor, demonstrating effective, cyclical detoxification of an OPC solution at high flow rate.Looking towards the future of ELM design, a novel, 3D printable, contractile-thermosensitive,double-network hydrogel was used to create thermo-responsive OPC degrading bioreactors, capable of autonomously controlling their performance

    Advance in Composite Gels

    Get PDF
    In the last few decades, various composite gels have been developed. In recent years, further advances have been made in the development of novel composite gels with potential applications in various fields. This reprint offers the latest findings of composite gels by experts throughout the world

    Dynamic hypoxic pre-conditioning of cells seeded in tissue-engineered scaffold to improve neovascularisation

    Get PDF
    Introduction: Tissue engineering (TE) is the potential solution to the global shortage of tissue and organs. However, the lack of adequate angiogenesis to TE scaffolds during the initial stages of implantation has hindered its success in vivo. Mesenchymal stem cells (MSC) have the most established track record for translational regenerative therapy and have been widely used in combination with TE scaffolds. Hypoxia is one of the main potentiators for upregulating angiogenic factors in MSC. However, fine-tuning their cellular function and behaviour is still not fully understood. This study aims to help increase the understanding of this process by determining the effects of in vitro hypoxic conditioning on enhancement of angiogenesis of MSC for the purpose of pre-clinical translational for TE application. Methods: The angiogenic potential of 3 different tissue sources (bone marrow, umbilical cord and adipose) MSC were initially determined for downstream pre-clinical application. We established the appropriate regime for in vitro dynamic hypoxia conditions in 2D and 3D hydrogel to enhance MSC angiogenic pathway using real-time continuous oxygen sensors and angiogenic cytokine profiling. Cell metabolism and proliferation effects were also evaluated using intravital Realtime-glo, D-luciferin (on transduced MSC) and microscopic Live-Dead stain techniques. We optimised seeding of cells on the tissue engineered dermal (INTEGRA®) for in vivo translational purpose and used targeted in vitro and ex vivo angiogenesis assays, which helped to determine aspects of the MSC conditioned media on endothelial migration, proliferation, morphogenesis and matrix degradation. Finally, the functional reproducibility of the in vitro angiogenic response was assessed using in vivo angiogenesis CAM assay and murine diabetic wound healing models. Results: Adipose derived MSC (adMSC) were found to have the most angiogenic potential in response to hypoxic conditioning. Dynamic hypoxia (DH) regime of changing oxygen levels from 21% to 1% when transitioning from T-flask subculture to multiwell plate seeding was most effective at eliciting pro-angiogenic response from adMSC for both in vitro 2D and 3D models compared to controls using static normoxia (21% oxygen) and static hypoxia (1%). Low seeding density of adMSC was found to be the most appropriate to ensure optimised cell adherence and survival post-seeding on TE dermal scaffold (INTEGRA®). It also minimised on localised hypoxic gradient induced oxidative stress by the seeded cells when compared to high seeding density techniques found on non-invasive oxygen monitoring. Conditioned media from DH seeded adMSC was shown to have enhanced angiogenic proteomic profile compared to the controls. In vitro angiogenesis assays showed better human endothelial cell migration and morphogenesis in scratch assay and tubular formation assay compared to controls. Preliminary ex vivo organ assay results using novel human umbilical arterial rings showed better endothelial out-sprouting and migration through embedded matrix compared to controls. Results from in vivo transplantation of adMSC seeded INTEGRA® scaffold showed a mixed response in the CAM assay, highlighting an unaccounted scaffold effect from INTEGRA® from the host. Histological sections showed increased vascular and host tissue infiltration into the scaffold. When evaluating the functional angiogenesis in murine wound healing models, although DH adMSC seeded scaffolds showed non-statistically significant increased rate of wound closure, there was significantly greater vessel density within the scaffold on histological evaluation in this group compared to controls. Conclusion: The results provide a better comprehension of how cells behave in 2D and 3D environments when cultured in dynamically changing oxygen environments. The study addresses important issues, such as the effects of chronic hypoxia on MSC, and how dynamic hypoxia can enhance angiogenic signalling. It also offers a crucial understanding of the in vitro oxygen culture environments for future research applications. Further insight into cell-scaffold interaction during in vivo transplantation was also established. The importance of having an appropriate in vivo model to determine if such in vitro angiogenic enhancement would translate to functionally improving neoangiogenesis and subsequent tissue regeneration in vivo was also highlighted in this study. Improving and advancing research into optimising and evaluating the in vitro environment for clinical application will undoubtedly have a huge impact on the future of cell therapy for regenerative medicine purposes

    Investigating a novel intramyocardial delivery method for induced pluripotent stem cell-derived cardiomyocytes

    Get PDF
    Cell therapy is a potential novel treatment for cardiac regeneration and numerous studies have attempted to transplant cells to regenerate the myocardium lost during myocardial infarction. To date, only minimal improvements to cardiac function have been reported. This is likely to occur from low cell retention following delivery and high cell death after transplantation. The thesis aimed to improve the delivery and engraftment of viable cells by using an injectable biomaterial which provides an implantable, biodegradable substrate for attachment and growth of cardiomyocytes derived from induced pluripotent stem cells (iPSC). The thesis describes the fabrication and characterisation of Thermally Induced Phase Separation (TIPS) microspheres, and functionalisation of the microspheres to enable cell attachment in xeno-free conditions. The selected formulation resulted in iPSC attachment, expansion, and retention of pluripotent phenotype. Differentiation of iPSC into cardiomyocytes was investigated and characterised, comparing in vitro culture to microsphere culture using flow cytometry, immunocytochemistry and western blotting techniques. Microsphere culture was shown to be protective against anoikis and compatible for injectable delivery. The in vivo compatibility of the microspheres was assessed using pre-clinical murine models. The microspheres were rendered trackable, using the computed tomography contrast agent barium sulphate, to assess the distribution after ultra-sound guided intramyocardial injections for targeted delivery. The findings suggest that barium sulphate-loaded microspheres can be used as a novel tool for optimising delivery techniques and tracking persistence and distribution of implanted products. Once in vivo compatibility was established, a cellularised microsphere formulation was delivered to the myocardium of immunocompromised mice, to compare the efficacy of biomaterial assisted versus suspension cell therapy. This work demonstrates that TIPS microcarriers offer a supporting matrix for culturing iPSC and iPSC derived cardiomyocytes in vitro and when implanted in vivo have the potential to be developed into an injectable biomaterial for cardiac regeneration

    Cell Culture

    Get PDF
    Cell culture is cell cloning technology that simulates in vivo environment conditions such as asepsis, appropriate temperature, and pH as well as certain nutritional conditions to enable cells to survive, grow, reproduce, and maintain their structure and function. Cell culture can be used to grow human, animal, plant, and microbial cells. Each type of cell culture has its own characteristics and essential conditions. This book focuses on the advanced technology and applications of cell culture in the research and practice of medical and life sciences. Chapters address such topics as primary cancer cell cultures, 2D and 3D cell cultures, stem cells, nanotechnology, and more

    Drug development progress in duchenne muscular dystrophy

    Get PDF
    Duchenne muscular dystrophy (DMD) is a severe, progressive, and incurable X-linked disorder caused by mutations in the dystrophin gene. Patients with DMD have an absence of functional dystrophin protein, which results in chronic damage of muscle fibers during contraction, thus leading to deterioration of muscle quality and loss of muscle mass over time. Although there is currently no cure for DMD, improvements in treatment care and management could delay disease progression and improve quality of life, thereby prolonging life expectancy for these patients. Furthermore, active research efforts are ongoing to develop therapeutic strategies that target dystrophin deficiency, such as gene replacement therapies, exon skipping, and readthrough therapy, as well as strategies that target secondary pathology of DMD, such as novel anti-inflammatory compounds, myostatin inhibitors, and cardioprotective compounds. Furthermore, longitudinal modeling approaches have been used to characterize the progression of MRI and functional endpoints for predictive purposes to inform Go/No Go decisions in drug development. This review showcases approved drugs or drug candidates along their development paths and also provides information on primary endpoints and enrollment size of Ph2/3 and Ph3 trials in the DMD space
    • …
    corecore